Personalized Nutrition in Patients with Type 2 Diabetes and Chronic Kidney Disease: The Two-Edged Sword of Dietary Protein Intake
- PMID: 35207788
- PMCID: PMC8878174
- DOI: 10.3390/jpm12020300
Personalized Nutrition in Patients with Type 2 Diabetes and Chronic Kidney Disease: The Two-Edged Sword of Dietary Protein Intake
Abstract
In type 2 diabetes (T2D), there is a general and strong focus on carbohydrate restriction. However, this may have unwarranted consequences for those with concomitant chronic kidney disease (CKD) since decreasing intake of carbohydrates implies a higher proportion of dietary protein, which is of critical debate in patients with CKD due to its ambiguous implications in maintaining either kidney function or nutritional status. We evaluated adherence to the protein recommendations, taking into account the nutritional status of patients with T2D with or without CKD. Patients were divided in three groups according to their estimated Glomerular Filtration Rate (eGFR): mild to no CKD (eGFR > 60 mL/min/1.73 m2), moderate CKD (eGFR 30-60 mL/min/1.73 m2), or advanced CKD (eGFR < 30 mL/min/1.73 m2). Regarding adherence to the protein recommendations, 17% of the patients without advanced CKD consumed < 0.8 g/kg/day, 29% of the patients with moderate CKD consumed > 1.3 g/kg/day, and 60% of the patients with advanced CKD consumed > 1.0 g/kg/day. In addition, patients with moderate- or advanced CKD tend to have a lower muscle mass, normalized by height, compared to patients with mild to no CKD (p < 0.001), while body mass index was not significantly different between patients with or without CKD (p = 0.44). We found that although dietary protein restriction has not been indicated in either of the CKD stages, approximately 10% had a dietary protein intake < 0.8 g/kg/day, with accompanying risks of malnourishment and sarcopenia. Our main advice is to maintain a dietary protein intake of at least 0.8 g/kg/day in order to prevent patients from becoming malnourished and sarcopenic.
Keywords: chronic kidney disease; dietary protein intake; sarcopenia; type 2 diabetes.
Conflict of interest statement
M.M.O., G.N. and S.J.L.B. have nothing to disclose. G.D.L. reports grants and personal fees from Sanofi, AstraZeneca, Astellas, Vifor, and Novo Nordisk outside the submitted work.
Figures
Similar articles
-
Influence of dietary protein intake on body composition in chronic kidney disease patients in stages 3-5: A cross-sectional study.Nefrologia (Engl Ed). 2018 Nov-Dec;38(6):647-654. doi: 10.1016/j.nefro.2018.06.007. Epub 2018 Oct 4. Nefrologia (Engl Ed). 2018. PMID: 30293714 English, Spanish.
-
Can renal nutrition education improve adherence to a low-protein diet in patients with stages 3 to 5 chronic kidney disease?J Ren Nutr. 2013 May;23(3):164-71. doi: 10.1053/j.jrn.2012.10.004. Epub 2012 Nov 27. J Ren Nutr. 2013. PMID: 23194841 Clinical Trial.
-
Optimal Protein Intake in Pre-Dialysis Chronic Kidney Disease Patients with Sarcopenia: An Overview.Nutrients. 2021 Apr 6;13(4):1205. doi: 10.3390/nu13041205. Nutrients. 2021. PMID: 33917381 Free PMC article. Review.
-
[Electrolyte and acid-base balance disorders in advanced chronic kidney disease].Nefrologia. 2008;28 Suppl 3:87-93. Nefrologia. 2008. PMID: 19018744 Spanish.
-
Nutritional status and the risk of malnutrition in older adults with chronic kidney disease - implications for low protein intake and nutritional care: A critical review endorsed by ERN-ERA and ESPEN.Clin Nutr. 2023 Apr;42(4):443-457. doi: 10.1016/j.clnu.2023.01.018. Epub 2023 Feb 2. Clin Nutr. 2023. PMID: 36857954 Review.
Cited by
-
Gene-Lifestyle Interactions in Renal Dysfunction: Polygenic Risk Modulation via Plant-Based Diets, Coffee Intake, and Bioactive Compound Interactions.Nutrients. 2025 Mar 6;17(5):916. doi: 10.3390/nu17050916. Nutrients. 2025. PMID: 40077791 Free PMC article.
References
-
- Sainsbury E., Kizirian N.V., Partridge S.R., Gill T., Colagiuri S., Gibson A.A. Effect of dietary carbohydrate restriction on glycemic control in adults with diabetes: A systematic review and meta-analysis. Diabetes Res. Clin. Pract. 2018;139:239–252. doi: 10.1016/j.diabres.2018.02.026. - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous